CARM logo

CARM
Carisma Therapeutics Inc

38,601
Mkt Cap
$1.68M
Volume
74,542.00
52W High
$1.27
52W Low
$0.0261
PE Ratio
0.21
CARM Fundamentals
Price
$0.0402
Prev Close
$0.0395
Open
$0.0452
50D MA
$0.0457
Beta
0.92
Avg. Volume
181,206.00
EPS (Annual)
-$1.46
P/B
-1.94
Rev/Employee
$426,782.61
$1.93
Loading...
Loading...
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
46

Frequently Asked Questions

What is Market Cap of Carisma Therapeutics Inc?
What is the 52-week high for Carisma Therapeutics Inc?
What is the 52-week low for Carisma Therapeutics Inc?
What is Carisma Therapeutics Inc stock price today?
What was Carisma Therapeutics Inc stock price yesterday?
What is the PE ratio of Carisma Therapeutics Inc?
What is the Price-to-Book ratio of Carisma Therapeutics Inc?
What is the 50-day moving average of Carisma Therapeutics Inc?
How many employees does Carisma Therapeutics Inc have?

Latest CARM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.